CNS & Neurological Disorders - Drug Targets
Title:Erratum
Volume: 15 Issue: 2
Export Options
About this article
Cite this article as:
Erratum, CNS & Neurological Disorders - Drug Targets 2016; 15 (2) . https://dx.doi.org/10.2174/187152731502160215130534
DOI https://dx.doi.org/10.2174/187152731502160215130534 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
42
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Supervised Disulfiram as Adjunct to Psychotherapy in Alcoholism Treatment
Current Pharmaceutical Design PET Imaging in Clinical Drug Abuse Research
Current Pharmaceutical Design Hyperfibrinogenemia is Significantly Associated with an Increased Risk of In-hospital Mortality in Acute Ischemic Stroke Patients
Current Neurovascular Research Engineering Antibodies for Therapy
Current Pharmaceutical Biotechnology The Effect of Cannabis on Perception of Time: A Critical Review
Current Pharmaceutical Design Positron Emission Tomography: Applications In Drug Discovery and Drug Development
Current Topics in Medicinal Chemistry Network Building of Proteins in a Biochemical Pathway: A Computational Biology Related Model for Target Discovery and Drug-Design
Current Bioinformatics Advances in Discovery of PDE10A Inhibitors for CNS-Related Disorders. Part 1: Overview of the Chemical and Biological Research
Current Drug Targets Oxidative Stress in the ICU
Current Nutrition & Food Science Limitations of Current Antiretroviral Agents and Opportunities for Development
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Neuropharmacology A Neurotrophic Rationale for the Therapy of Neurodegenerative Disorders
Current Alzheimer Research Neuropathic Pain: Some Clues for Future Drug Treatments
Mini-Reviews in Medicinal Chemistry Human T-Cell Leukemia Virus Type 1: Transition from Latent Infection to Pathogenic Progression and Implications for Molecular Therapy
Current Cancer Therapy Reviews The Radiosensitizing Effect of Olanzapine as an Antipsychotic Medication on Glioblastoma Cell
Current Radiopharmaceuticals Recent Advances in Medicinal Chemistry to Treat Filariasis and Helminthiasis
Current Topics in Medicinal Chemistry Neonatal Abstinence Syndrome Management: A Review of Recent Evidence
Reviews on Recent Clinical Trials Neuro-toxic and Reproductive Effects of BPA
Current Neuropharmacology Inhibition of the PERK-dependent Unfolded Protein Response Signaling Pathway Involved in the Pathogenesis of Alzheimer’s Disease
Current Alzheimer Research Mechanistic Insights into Mode of Action of a Potent Natural Antagonist of Orexin Receptor-1 by Means of High Throughput Screening and Molecular Dynamics Simulations
Combinatorial Chemistry & High Throughput Screening